The present invention relates to a compound of the following formula (I):or a pharmaceutically acceptable salt or solvate thereof, a stereoisomer or a mixture of stereoisomers in any ratio, or a water-soluble derivative,as well as to methods for preparing same and to the use thereof, in particular in the treatment of cancer.
